Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Non-Current Deferred Tax Liability: 2017-2018

Historic Non-Current Deferred Tax Liability for Altimmune (ALT) over the last 2 years, with Dec 2018 value amounting to $58,500.

  • Altimmune's Non-Current Deferred Tax Liability fell 98.68% to $58,500 in Q2 2019 from the same period last year, while for Jun 2019 it was $58,500, marking a year-over-year decrease of 98.68%. This contributed to the annual value of $58,500 for FY2018, which is 99.01% down from last year.
  • Altimmune's Non-Current Deferred Tax Liability amounted to $58,500 in FY2018, which was down 99.01% from $5.9 million recorded in FY2017.
  • Over the past 5 years, Altimmune's Non-Current Deferred Tax Liability peaked at $5.9 million during FY2017, and registered a low of $58,500 during FY2018.
  • For the 2-year period, Altimmune's Non-Current Deferred Tax Liability averaged around $3.0 million, with its median value being $3.0 million (2017).
  • Data for Altimmune's Non-Current Deferred Tax Liability shows a maximum YoY plummeted of 99.01% (in 2018) over the last 5 years.
  • Over the past 2 years, Altimmune's Non-Current Deferred Tax Liability (Yearly) stood at $5.9 million in 2017, then crashed by 99.01% to $58,500 in 2018.